Медицинская иммунология (Jul 2014)

THYMOPOIESIS INTENSITY IN PATIENTS WITH BRONCHIAL ASTHMA, DEPENDING ON DURATION OF THE DISEASE

  • E. A. Blinova,
  • V. M. Nepomniashchikh,
  • V. S. Kozhevnikov

DOI
https://doi.org/10.15789/1563-0625-2012-1-2-163-168
Journal volume & issue
Vol. 14, no. 1-2
pp. 163 – 168

Abstract

Read online

Abstract. Functional activity of thymus in normal donors and patients with various clinical forms of bronchial asthma was evaluated by means of assessing TREC-positive T-cell numbers. In spite of well-known alterations in parameters of T-cell homeostasis, TREC levels in CD4+and CD8+ lymphocytes from the patients with asthma did not differ significantly from those in donors. There were also no significant differences in TREC-containing cell numbers, dependent on clinical types of bronchial asthma and IgE levels. However, the patients with a recent disease onset (duration of several days to one year) showed increased TREC positivity in CD4+ and CD8+ lymphocytes, as compared with donors and those patients who underwent basal therapy with glucocorticoids, and during long-term disorder (> 1 year). Enhanced thymopoiesis at initial stages of the disease may be associated with thymic stromal lymphopoietin which contributes to development of bronchial asthma, and normally participates in the process of T cell production.

Keywords